Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P Ahern

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
Aging|February 22, 2019
Towards a more precise and individualized assessment of breast cancer riskMarie E Wood, Nicholas H Farina, Thomas P Ahern, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 19, 2017
Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening PopulationThomas P Ahern, Brian L Sprague, Michael C S Bissell, et al.
Perioperative Care and Operating Room Management|May 28, 2019
The Impact of an Acute Care Surgery Model on General Surgery Service ProductivityAdam N Paine, Bradley L Krompf, Edward C Borrazzo, et al.
American Journal of Epidemiology|February 9, 2022
Sampling Validation Data to Achieve a Planned Precision of the Bias-Adjusted Estimate of EffectLindsay J Collin, Richard F MacLehose, Thomas P Ahern, et al.
Cancer Causes & Control : CCC|July 3, 2019
Circulating lipids, mammographic density, and risk of breast cancer in the Nurses' Health Study and Nurses' Health Study IISarah A Lucht, A Heather Eliassen, Kimberly A Bertrand, et al.
Acta Oncologica (Stockholm, Sweden)|April 9, 2016
Pak1, adjuvant tamoxifen therapy, and breast cancer recurrence risk in a Danish population-based studyThomas P Ahern, Deirdre P Cronin-Fenton, Timothy L Lash, et al.
Epidemiology (Cambridge, Mass.)|June 3, 2020
Adaptive Validation Design: A Bayesian Approach to Validation Substudy Design With Prospective Data CollectionLindsay J Collin, Richard F MacLehose, Thomas P Ahern, et al.
Journal of the National Cancer Institute|August 5, 2011
Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort studyThomas P Ahern, Lars Pedersen, Maja Tarp, et al.
Epidemiology (Cambridge, Mass.)|May 18, 2018
Re: Beta Blockers and Improved Progression-Free Survival in Patients With Advanced HER2 Negative Breast CancerGitte Vrelits Sørensen, Deirdre P Cronin-Fenton, Henrik Toft Sørensen, et al.
Clinical Epidemiology|August 5, 2021
Assessing Techniques for Quantifying the Impact of Bias Due to an Unmeasured Confounder: An Applied ExampleJulie Barberio, Thomas P Ahern, Richard F MacLehose, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
Aging|February 22, 2019
Towards a more precise and individualized assessment of breast cancer riskMarie E Wood, Nicholas H Farina, Thomas P Ahern, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 19, 2017
Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening PopulationThomas P Ahern, Brian L Sprague, Michael C S Bissell, et al.
Perioperative Care and Operating Room Management|May 28, 2019
The Impact of an Acute Care Surgery Model on General Surgery Service ProductivityAdam N Paine, Bradley L Krompf, Edward C Borrazzo, et al.
American Journal of Epidemiology|February 9, 2022
Sampling Validation Data to Achieve a Planned Precision of the Bias-Adjusted Estimate of EffectLindsay J Collin, Richard F MacLehose, Thomas P Ahern, et al.
Cancer Causes & Control : CCC|July 3, 2019
Circulating lipids, mammographic density, and risk of breast cancer in the Nurses' Health Study and Nurses' Health Study IISarah A Lucht, A Heather Eliassen, Kimberly A Bertrand, et al.
Acta Oncologica (Stockholm, Sweden)|April 9, 2016
Pak1, adjuvant tamoxifen therapy, and breast cancer recurrence risk in a Danish population-based studyThomas P Ahern, Deirdre P Cronin-Fenton, Timothy L Lash, et al.
Epidemiology (Cambridge, Mass.)|June 3, 2020
Adaptive Validation Design: A Bayesian Approach to Validation Substudy Design With Prospective Data CollectionLindsay J Collin, Richard F MacLehose, Thomas P Ahern, et al.
Journal of the National Cancer Institute|August 5, 2011
Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort studyThomas P Ahern, Lars Pedersen, Maja Tarp, et al.
Epidemiology (Cambridge, Mass.)|May 18, 2018
Re: Beta Blockers and Improved Progression-Free Survival in Patients With Advanced HER2 Negative Breast CancerGitte Vrelits Sørensen, Deirdre P Cronin-Fenton, Henrik Toft Sørensen, et al.
Clinical Epidemiology|August 5, 2021
Assessing Techniques for Quantifying the Impact of Bias Due to an Unmeasured Confounder: An Applied ExampleJulie Barberio, Thomas P Ahern, Richard F MacLehose, et al.
Pageof 11